In this course, we will address endometrial cancer care from the role of surgery, radiation, and systemic treatment along with the application and impact of molecular classification in treatment options. With the recent FDA approval of new treatments in endometrial cancer, we will also discuss the process of these approvals.

Moderator Introductions
David Gaffney, MD, PhD, FACR, FABS, FASTRO, Katherine Fuh, MD, PhD, Casey Cosgrove, MD

The Cornerstone of Endometrial Cancer Management: Surgery
Emma Rossi, MD

The Practical Clinical Application of Molecular Classification of Endometrial Cancer
Casey Cosgrove, MD

Eye of the Beholder - Pathology and CAP Biomarker Testing in Endometrial Cancer
Tony Karnezis, MD, PhD

Case I - Who Really Needs Chemo Stage I/II?
Helen MacKay, MD

Case II - Who Really Needs RT in Stage I/II?
David Gaffney, MD, PhD, FACR, FABS, FASTRO

Case III - Role of Radiation for Stage III Disease: Really?
Jyoti Mayadev, MD

Panel Discussion
Emma Rossi, MD, Casey Cosgrove, MD, Tony Karnezis, MD, PhD, Helen MacKay, MD, David Gaffney, MD, PhD, FACR, FABS, FASTRO, Jyoti Mayadev, MD, Matthew Powell, MD, Ramez Eskander, MD

Modern/Maintenance Treatments for Advanced Stage Disease
Shannon Westin, MD

Molecular Case Based Discussion: NSMP Molecular Profile - Early and Advanced Stage
Linda Duska, MD, MPH, Britt Erickson, MD

Molecular Case Based Discussion: p53/HER2/MMRp - Early and Advanced Stage
Roisin O'Cearbhaill, MD

Case IV: Recurrence - Location... Location... Location: Approaches of Care for Pelvic vs. Extra-Pelvic Recurrences
David Gaffney, MD, PhD, FACR, FABS, FASTRO, Brian Slomovitz, MD

Panel Discussion
Shannon Westin, MD, Linda Duska, MD, MPH, Britt Erickson, MD, Roisin O'Cearbhaill, MD, David Gaffney, MD, PhD, FACR, FABS, FASTRO, Matthew Powell, MD, Ramez Eskander, MD

The FDA Focus on New Horizons
Stephanie Wethington, MD

This course is not eligible for CE.

This course was recorded on March 14, 2025 in Seattle, WA at the SGO 2025 Annual Meeting on Women's Cancer.